web counter
LEXO PA REKLAMA!

SHKARKO APP

App Store
Google Play

First drug for teenage hair loss approved

2023-06-28 11:01:00, Shëndeti CNA

First drug for teenage hair loss approved

The US Food and Drug Administration has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease, the company said.

The drug, called Litfulo, is approved for people aged 12 and over who suffer from severe alopecia areata (AA), a condition where the immune system attacks hair follicles and causes the hair to fall out, often in clumps.

The FDA's decision makes Litfulo the first drug approved to treat the condition in adolescents.

The drug, which will be available in the coming weeks, is also the second systemic treatment to win approval after Eli Lilly's Olumiant, used to treat the condition in adults.

Systemic treatments usually target the cause of the disease and affect the function of the whole body including the immune system. Other treatments for alopecia areata—which include oral steroids and topical medications—target only certain affected parts of the body.

Pfizer can price its product competitively with Olumiant, BMO Capital analyst Keith Tapper said before the approval./ CNA





Lajmet e fundit nga